Mawer Investment Management Ltd. Abb Vie Inc. Transaction History
Mawer Investment Management Ltd.
- $21.3 Billion
- Q4 2024
A detailed history of Mawer Investment Management Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mawer Investment Management Ltd. holds 262,150 shares of ABBV stock, worth $55.6 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
262,150
Previous 275,336
4.79%
Holding current value
$55.6 Million
Previous $54.4 Million
14.33%
% of portfolio
0.22%
Previous 0.25%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
4,111Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$36.7 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$28.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.9 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$11 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.41 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $375B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...